Company: DGLY
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001641172-25-011765
Chunk: 50

Company: DIGITAL ALLY, INC.
Filing Date: 2025-05-20
Form: 10-Q
Item: Part I, Item 1
Chunk 50
---
 
     4.38% 
     3.96%
  
    Dividend 
     —% 
     —%
  
    Remaining contractual term 
     3.3 years  
     3.0 years 
  
    Exercise price 
     110.00 – 150.00  
     110.00
                                            – 150.00  
  
    Common stock issuable under the warrants 
     56,250  
     56.250 

    31

NOTE 12 - STOCKHOLDERS’ EQUITY

February 2025 Public Equity Offering

On February 13,
2025, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Aegis Capital Corp. (the
“Underwriter”) for the sale and issuance of (i) 392,500 units  at a public offering price per
unit of $3.00 with each Unit consisting of one share of Common Stock,  one Series A warrant to purchase
one share of Common Stock at an exercise price of $3.75 per share and one Series B warrant to purchase one share of Common Stock at
an exercise price of $6.00 and (ii) 4,607,500 pre-funded units at a public offering price of $2.98 per pre-funded unit, with each
pre-funded unit consisting of one pre-funded warrant exercisable for one share of Common Stock at an exercise price of $0.001 per
share, one Series A warrant and one Series B warrant. The pre-funded warrants were immediately exercisable and may be exercised
at any time until all of the pre-funded warrants are exercised in full.

The Series A and
Series B warrants are exercisable only upon receipt of stockholder approval of (i) certain terms in the Series A and B warrants and
the issuance of the shares of Common Stock issuable upon the exercise of such Series A and Series B warrants, as may be required by
the applicable rules and regulations of The Nasdaq Stock Market LLC and (ii) if necessary, a proposal to amend the Company’s
Articles of Incorporation, to increase the authorized share capital of the Company to an amount sufficient to cover the shares of
Common Stock issuable upon the exercise of the Series A and Series B warrants. The Series A warrants will be exercisable commencing
upon the date of public notice of Stockholder Approval until five years after such date, and the Series B Warrants will be